Description

NSE notifies commencement of trading in Rights Entitlements (REs) of Healthcare Global Enterprises Limited (HCG-RE) from March 11, 2026, in the Trade to Trade segment under compulsory demat.

Summary

NSE has notified the admission of Rights Entitlements (REs) of Healthcare Global Enterprises Limited to dealings on the Capital Market segment effective March 11, 2026. The REs will trade under the symbol HCG-RE in the Trade to Trade (BE) segment under compulsory demat for all investors, with a total of 8,294,566 REs available for trading.

Key Points

  • Symbol: HCG-RE; Series: BE; ISIN: INE075I20017
  • Total Rights Entitlements available for trading: 8,294,566
  • Market lot size: 1
  • Trading is in the Trade to Trade segment under compulsory demat for all investors
  • Trading members must inform clients that REs are not ordinary shares of the company
  • Contract notes/bills must include a disclaimer that RE purchase only confers the right to participate in the rights issue or renounce the REs before the issue closes
  • Unsubscribed and unrenounced REs will lapse and be extinguished after the Issue Closing Date

Regulatory Changes

No new regulatory changes. This circular is issued in pursuance of Regulation 3.1.1 (admission of securities to dealings) and Regulation 2.5.5 (lot sizes) of the National Stock Exchange (Capital Market) Trading Regulations Part A.

Compliance Requirements

  • Trading members must inform all clients about the commencement of trading in REs, including the ISIN (INE075I20017), and clarify that REs are not ordinary shares.
  • Trading members must prominently include a disclaimer in contract notes/bills for RE purchases, stating that the purchase only gives the right to participate in the rights issue by making an application with requisite application money, or to renounce the REs before the issue closes.
  • REs that are neither subscribed nor renounced on or before the Issue Closing Date will lapse and be extinguished.

Important Dates

  • Effective date of circular: March 11, 2026
  • Trading period for renunciation of REs: March 11, 2026 to March 20, 2026
  • Date of suspension of trading in REs: March 23, 2026

Impact Assessment

This circular is of moderate impact, primarily affecting existing shareholders of Healthcare Global Enterprises Limited who are eligible for the rights issue and trading members facilitating RE transactions. The Trade to Trade designation means there is no intraday trading in these REs; all transactions must result in delivery. Investors who do not subscribe or renounce their REs before March 20, 2026 risk losing their entitlements as the REs will lapse after the issue closing date.

Impact Justification

Routine listing of Rights Entitlements for a specific company; relevant to existing shareholders of Healthcare Global Enterprises Limited and trading members handling the rights issue.